Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification

John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies

Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington

Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins

Volume Reduction and Process Optimization with Cadence Inline Concentrator

View All Featured Articles

Headline News

FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy


Moderna advances Bundibugyo ebolavirus vaccine toward Phase II/III study


FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Real Time Monitoring of Bioprocess and Beyond – A Process Analytical Perspective

Presented by Dhanuka Wasalathanthri, Senior Scientist at Bristol Myers Squibb and Julia Ding, Head, Global Process Analytical Development at Bristol Myers Squibb and Eric Carlson, Ph.D., President & CEO, Protein Metrics Inc.
16th November 2020


Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review

Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022


HME lipidic Pellets for Paediatric Application. An Investigation of the Effect and Stability on Drug Dissolutions

Presented by Dennis Douroumis, Professor in Pharmaceutical Technology and Process Engineering at University of Greenwich
11th June 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia